Booth Andrew bought ABCL

February 27, 2026 · Form 4 insider transaction

Booth Andrew bought 42,600 shares of AbCellera Biologics Inc. at $3.42 per share, a transaction worth $145.7K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.